CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET

Serial Number 79080475
Registration 4033261
404

Registration Progress

Application Filed
Feb 15, 2010
Under Examination
Approved for Publication
Feb 8, 2011
Published for Opposition
Feb 8, 2011
Registered
Oct 4, 2011

Trademark Image

CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET

Basic Information

Serial Number
79080475
Registration Number
4033261
Filing Date
February 15, 2010
Registration Date
October 4, 2011
Published for Opposition
February 8, 2011
Cancellation Date
February 16, 2020
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
404
Status Date
Feb 16, 2020

Rights Holder

IPSEN PHARMA S.A.S.

99
Address
65 quai Georges Gorse
F-92100 BOULOGNE BILLANCOURT
FR

Ownership History

IPSEN PHARMA S.A.S.

Original Applicant
99
FR

IPSEN PHARMA S.A.S.

Owner at Publication
99
FR

IPSEN PHARMA S.A.S.

Original Registrant
99
FR

Legal Representation

Attorney
William S. Frommer & Marilyn M. Brogan

USPTO Deadlines

Next Deadline
2157 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2011-10-04)
Due Date
October 04, 2031
Grace Period Ends
April 04, 2032

Application History

40 events
Date Code Type Description Documents
Sep 4, 2020 DENC E NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Loading...
Sep 4, 2020 DETH P DEATH OF INTERNATIONAL REGISTRATION Loading...
Mar 8, 2019 INNT P TOTAL INVALIDATION PROCESSED BY THE IB Loading...
Jan 25, 2019 INPC P INVALIDATION PROCESSED Loading...
Jan 25, 2019 INTS P TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Loading...
Jan 11, 2019 INTR P TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Loading...
May 11, 2018 C71T O CANCELLED SECTION 71 Loading...
Mar 9, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 9, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 1, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 8, 2013 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
May 25, 2012 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Mar 12, 2012 FIMP P FINAL DISPOSITION PROCESSED Loading...
Mar 12, 2012 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jan 4, 2012 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Oct 4, 2011 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 14, 2011 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Sep 14, 2011 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Aug 23, 2011 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Mar 9, 2011 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Feb 19, 2011 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Feb 8, 2011 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 8, 2011 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 3, 2011 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Feb 3, 2011 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jan 5, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Dec 20, 2010 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 10, 2010 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 10, 2010 ALIE A ASSIGNED TO LIE Loading...
Dec 10, 2010 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 23, 2010 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 26, 2010 RFNT P REFUSAL PROCESSED BY IB Loading...
May 25, 2010 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 25, 2010 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 25, 2010 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
May 24, 2010 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 18, 2010 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 13, 2010 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 9, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 8, 2010 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET"